Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2005
03/17/2005US20050059655 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005US20050059652 Open chain prolyl urea-related modulators of androgen receptor function
03/17/2005CA2537292A1 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
03/17/2005CA2536975A1 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
03/17/2005CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
03/16/2005EP1513829A2 Nicotinoyl derivatives as herbicidal compounds
03/16/2005EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
03/16/2005EP1513825A2 Anti tubercular drug: compositions and methods
03/16/2005EP1513814A1 Novel piperidine compound
03/16/2005EP1513813A1 Opioid receptor antagonists
03/16/2005EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors
03/16/2005EP1513513A1 I CIS /i -2,6-DISUBSTITUTED PIPERIDINES FOR THE TREATMENT OF PSYCHOSTIMULANT ABUSE AND WITHDRAWAL, EATING DISORDERS, AND CENTRAL NERVOUS SYSTEM DISEASES AND PATHOLOGIES
03/16/2005EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors
03/16/2005EP1319054B1 Liquid crystal mixture
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
03/16/2005CN1594293A Process for synthesizing lacidipine of antihypertensive drugs
03/16/2005CN1594292A Chiral dihydropyridone derivatives and process for the preparation thereof
03/16/2005CN1193019C Method and reagents for N-alkylating ureides
03/16/2005CN1193002C Compounds with particular structure and anticancer activity and its preparing process
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867222 Nociceptin analogs
03/15/2005US6867221 Cyclic amine compounds and pharmaceutical composition containing the same
03/15/2005US6867220 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
03/15/2005US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm
03/15/2005US6867202 Treatment of insulin resistance
03/15/2005CA2279779C Process for preparation of substituted 3-hydroxypiperidines
03/10/2005WO2005021525A1 Aryl piperidine amides
03/10/2005WO2005021523A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005WO2005021506A1 Synthesis of 1-[4-(2-methoxyphenyl) piperazin-1-yl]-3-(2,6-dioxopiperidin-1-yl) propane
03/10/2005WO2005021505A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005WO2005021500A1 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005US20050054627 Cyclic derivatives as modulators of chemokine receptor activity
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2537487A1 Piperazine substituted compounds used as calcium channel blockers
03/10/2005CA2537349A1 The claimed invention relates to novel 4-piperidinecarboxamide and the use thereof for the preparation of medicaments against 5-ht2a receptor-related disorders
03/10/2005CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof
03/10/2005CA2536461A1 Aryl piperidine amides
03/09/2005EP1512683A1 Novel opiate compounds, methods of making and methods of use
03/09/2005EP1512397A1 O-substituted hydroxyaryl derivatives
03/09/2005EP1511729A1 Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
03/09/2005EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/09/2005EP1511704A1 Polymerisation inhibitor
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1202969B1 Biphenyl derivatives, production thereof and use as medicines
03/09/2005EP1126849B1 Heterocyclic potassium channel inhibitors
03/09/2005EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same
03/09/2005EP0869792B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
03/09/2005CN1592746A LFA-1 antagonist compounds
03/09/2005CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use
03/09/2005CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
03/09/2005CN1590373A Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol
03/09/2005CN1192019C Cyclic amine derivatives
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/08/2005US6864385 Process for the preparation of 4-haloalkylnicotinonitriles
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864372 Process for the production of sulfonic esters
03/08/2005US6864266 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists
03/08/2005CA2261680C Fluorine-containing 1,4-disubstituted piperidine derivatives
03/03/2005WO2005019200A2 Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors
03/03/2005WO2005019177A1 Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
03/03/2005WO2005019176A1 Substituted amino-aza-cyclohexanes
03/03/2005WO2005019175A1 Fexofenadine polymorphs and processes of preparing the same
03/03/2005WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF
03/03/2005WO2005018643A1 Metabolites of 1-{3-4`4-(2-methoxyphenyl) piperazin-1-yl!-propyl}-piperidine-2, 6-dione for use in the treatment of benign prostatic hyperplasia
03/03/2005WO2005018557A2 Substituted pyridinones
03/03/2005WO2005000309A3 Chemical compounds
03/03/2005WO2004103309A3 Immunosuppressant compounds and compositions
03/03/2005WO2004103306A3 Immunosuppressant compounds and compositions
03/03/2005US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis
03/03/2005US20050049286 Cardiovascular homeostasis through combination of direct neuronal control and systemic neurohormonal activation
03/03/2005US20050049281 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
03/03/2005US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate
03/03/2005US20050049279 Sustained release daily dosage form comprising D-threo methylphenidate; substantially free of L-threo and erythro optical isomers; minimizing side effects, increasing efficacy
03/03/2005US20050049254 Substituted heterocyclic compounds
03/03/2005US20050049239 Type 2 glycine transporter inhibitors; muscle spasticity, tinnitus, epilepsy neuropathic pain, obesity
03/03/2005CA2537257A1 Fexofenadine polymorphs and processes of preparing the same
03/02/2005EP1510515A1 Phenylglycine derivatives as serine protease inhibitors
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509495A1 Anilino liver x-receptor modulators
03/02/2005EP1509226A2 Small molecule inhibitors of her2 expression
03/02/2005EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction
03/02/2005EP1042279B1 Substituted beta-alanines
03/02/2005EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
03/02/2005CN1589262A Cyanoguanidine prodrugs
03/02/2005CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/02/2005CN1589153A Preventives/remedies for urinary disturbance
03/02/2005CN1191234C Process for producing piperidine compound
03/02/2005CN1191233C N-substituted nitrogen heterocyclic compound
03/02/2005CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
03/01/2005US6861530 Piperidine derivatives
03/01/2005CA2368479C Method of producing 3,4-dehydroprolines and 3,4-dehydropiperidines
02/2005
02/24/2005WO2005016902A1 N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
02/24/2005WO2005016885A2 COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE
02/24/2005WO2005016884A1 Cyclopropyl derivatives as nk3 receptor antagonists
02/24/2005WO2005016883A2 Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 380